1217646

Zhejiang Liaoyuan Pharmaceutical Co., Ltd. — FEI 3007388805

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 25, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Taizhou (China)